Detalles de la búsqueda
1.
Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection.
Antimicrob Agents Chemother;
: e0023624, 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38780262
2.
Characterization of ß-Lactamase Content of Ceftazidime-Resistant Pathogens Recovered during the Pathogen-Directed Phase 3 REPRISE Trial for Ceftazidime-Avibactam: Correlation of Efficacy against ß-Lactamase Producers.
Antimicrob Agents Chemother;
63(6)2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30910899
3.
Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia.
Antimicrob Agents Chemother;
62(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038277
4.
Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms.
J Antimicrob Chemother;
73(12): 3346-3354, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30219857
5.
Molecular ß-Lactamase Characterization of Aerobic Gram-Negative Pathogens Recovered from Patients Enrolled in the Ceftazidime-Avibactam Phase 3 Trials for Complicated Intra-abdominal Infections, with Efficacies Analyzed against Susceptible and Resistant Subsets.
Antimicrob Agents Chemother;
61(6)2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28348155
6.
Retrospective molecular analysis of DIM-1 metallo-ß-lactamase discovered in Pseudomonas stutzeri from India in 2000.
Antimicrob Agents Chemother;
58(1): 596-8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24145536
7.
Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates.
Antimicrob Agents Chemother;
58(1): 577-80, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24126582
8.
Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel ß-lactamases, GES-22 and VIM-35.
Antimicrob Agents Chemother;
58(12): 7358-66, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25267671
9.
Erratum for Drusano et al., "Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia".
Antimicrob Agents Chemother;
62(4)2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29588353
10.
Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs.
J Clin Microbiol;
51(1): 117-24, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23100350
11.
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
J Clin Microbiol;
51(8): 2571-81, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23720791
12.
Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America.
Microbiol Spectr;
11(1): e0467322, 2023 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645286
13.
Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010.
Antimicrob Agents Chemother;
56(3): 1639-42, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22183169
14.
Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance programme.
Mycopathologia;
174(4): 259-71, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22580756
15.
CEM-101 activity against Gram-positive organisms.
Antimicrob Agents Chemother;
54(5): 2182-7, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20176910
16.
Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.
Antimicrob Agents Chemother;
54(6): 2655-9, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20368396
17.
Performance of fusidic acid (CEM-102) susceptibility testing reagents: broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus.
J Clin Microbiol;
48(3): 972-6, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20053856
18.
Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of ß-lactamase Resistance Genes and Lineage Background in the United States.
Open Forum Infect Dis;
6(Suppl 1): S69-S78, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30895217
19.
Analyses of a Ceftazidime-Avibactam-Resistant Citrobacter freundii Isolate Carrying blaKPC-2 Reveals a Heterogenous Population and Reversible Genotype.
mSphere;
3(5)2018 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30258039
20.
Molecular ß-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets.
Int J Antimicrob Agents;
52(2): 287-292, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29654893